TrialJournal of gastroenterology2019

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.

Ryosuke Tateishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.